Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 374.90M | $ 273.70M | $ 351.80M | $ 229.70M | $ 240.20M |
Total Assets | $ 1.58B | $ 1.64B | $ 1.61B | $ 1.47B | $ 1.47B |
Total Debt | $ 101.00M | $ 102.00M | $ 102.50M | $ 103.30M | $ 104.20M |
Net Debt | $ -273.90M | $ -171.70M | $ -249.30M | $ -126.40M | $ -136.00M |
Total Liabilities | $ 696.10M | $ 793.70M | $ 706.80M | $ 601.70M | $ 641.90M |
Stockholders Equity | $ 883.10M | $ 846.30M | $ 901.60M | $ 869.10M | $ 825.30M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |